| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |